Whether you have osteoarthritis, otherwise known as degenerative joint
disease or an inflammatory type of arthritis such as rheumatoid or
psoriatic arthritis, there are a number of things that you can do to
develop an effective arthritis pain management program to help you get the most out of each day.

Drug developer Pfizer Inc. said Thursday that its potential
rheumatoid arthritis drug met key treatment goals in two late-stage
studies.

The drug candidate tofacitinib, formerly called tasocitinib, met
its key goals of reducing signs and symptoms of the condition in
separate studies on patients over a 12-month and six-month period.
Rheumatoid arthritis is a chronic inflammatory disease typically
affecting joints.

Bristol-Myers Squibb Co. is likely to win approval for a new version
of its rheumatoid arthritis drug Orencia after gaining approval for its
kidney transplant drug Nulojix, a Citi Investment Research analyst said
Thursday.Analyst John Boris said the Food and Drug Administration delayed
approval of Nulojix in part because of manufacturing problems at a plant
in Puerto Rico. Now that those problems have been resolved and the drug
has been approved, Boris said it is more likely the FDA will approve
Bristol-Myers' new version of Orencia.